The Kimmel Cancer Center (KCC) Administration serves to meet the operational and financial needs of the Center, providing cost-effective management and helping to ensure that the goals of the Center are realized. Administration provides key support to the Center Director and Senior Leaders, the Programs and Shared Resources, the Executive Committee, the internal Basic Science and Clinical Science Advisory Committees, and the External Scientific Advisory Committee. KCC Administration participates in the planning and implementation of all activities throughout the programs and shared resources of the Center. Overall responsibility for the operation of Administration lies with the Executive Director, Richard L. Davidson, Ph.D., who has over 35 years'experience in the administration and management of large-scale academic units. Dr. Davidson also serves as Associate Director for Shared Resources, overseeing the activities of all the KCC shared resources. The administrative team under Dr. Davidson includes individuals for financial analysis and management, for liaison and integration with the clinical research enterprise, and for clerical assistance. Administration serves as the link between the Center and the University and Hospital offices for administration, financial affairs, space management, maintenance, construction, human resources, intellectual property, information technology, and legal counsel. The major activities of Administration involve the following areas;1) financial management of all CCSG accounts 2) operational and financial management of the shared resources;3) space management, maintenance, and renovation;4) strategic planning activities;5) Center retreats, symposia, seminars, and meetings;6) clinical trials activities;7) KCC Grand Rounds;8) faculty recruitment;9) human resources;10) educational and training programs;and 11) planning for and preparation of CCSG submissions.

Public Health Relevance

Cancer Center Administration is responsible for taking care of the operational and financial needs of the Center. Administration supports all the other components of the Cancer Center Support Grant. It also serves as the link between the Cancer Center and a number of offices within the University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-15
Application #
8753679
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
15
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Peng, Weidan; Furuuchi, Narumi; Aslanukova, Ludmila et al. (2018) Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 38:
Waldman, Scott A; Camilleri, Michael (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:1543-1552
Sullivan-Reed, Katherine; Bolton-Gillespie, Elisabeth; Dasgupta, Yashodhara et al. (2018) Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells. Cell Rep 23:3127-3136
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Lapadula, Dominic; Farias, Eduardo; Randolph, Clinita E et al. (2018) Effects of Oncogenic G?q and G?11 Inhibition by FR900359 in Uveal Melanoma. Mol Cancer Res :
Vite, Alexia; Zhang, Caimei; Yi, Roslyn et al. (2018) ?-Catenin-dependent cytoskeletal tension controls Yap activity in the heart. Development 145:
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469

Showing the most recent 10 out of 807 publications